These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38186868)

  • 21. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.
    Ford I; Bezlyak V; Stott DJ; Sattar N; Packard CJ; Perry I; Buckley BM; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J
    PLoS Med; 2009 Jan; 6(1):e16. PubMed ID: 19166266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral adsorbents for preventing or delaying the progression of chronic kidney disease.
    Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
    Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Mann JFE; Fonseca V; Mosenzon O; Raz I; Goldman B; Idorn T; von Scholten BJ; Poulter NR
    Circulation; 2018 Dec; 138(25):2908-2918. PubMed ID: 30566006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
    Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of High Serum Adiponectin Level With Adverse Cardiovascular Outcomes and Progression of Coronary Artery Calcification in Patients With Pre-dialysis Chronic Kidney Disease.
    Suh SH; Oh TR; Choi HS; Kim CS; Lee J; Oh YK; Jung JY; Lee KB; Oh KH; Ma SK; Bae EH; Kim SW
    Front Cardiovasc Med; 2021; 8():789488. PubMed ID: 35097010
    [No Abstract]   [Full Text] [Related]  

  • 27. L-shaped association of serum 25-hydroxyvitamin D with all-cause and cardiovascular mortality in older people with chronic kidney disease: results from the NHANES database prospective cohort study.
    Li R; Li Y; Fan Z; Liu Z; Lin J; He M
    BMC Public Health; 2023 Jun; 23(1):1260. PubMed ID: 37380964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
    Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
    J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
    Shurraw S; Hemmelgarn B; Lin M; Majumdar SR; Klarenbach S; Manns B; Bello A; James M; Turin TC; Tonelli M;
    Arch Intern Med; 2011 Nov; 171(21):1920-7. PubMed ID: 22123800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultraprocessed Foods and Kidney Disease Progression, Mortality, and Cardiovascular Disease Risk in the CRIC Study.
    Sullivan VK; Appel LJ; Anderson CAM; Kim H; Unruh ML; Lash JP; Trego M; Sondheimer J; Dobre M; Pradhan N; Rao PS; Chen J; He J; Rebholz CM;
    Am J Kidney Dis; 2023 Aug; 82(2):202-212. PubMed ID: 37028638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Calcification Propensity and Clinical Events in CKD.
    Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
    Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus.
    Cernaro V; Loddo S; Macaione V; Ferlazzo VT; Cigala RM; Crea F; De Stefano C; Genovese ARR; Gembillo G; Bolignano D; Santoro D; Vita R; Buemi M; Benvenga S
    Int Urol Nephrol; 2020 Jun; 52(6):1125-1133. PubMed ID: 32314169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Cohen JB; Yang W; Li L; Zhang X; Zheng Z; Orlandi P; Bansal N; Deo R; Lash JP; Rahman M; He J; Shafi T; Chen J; Cohen DL; Matsushita K; Shlipak MG; Wolf M; Go AS; Feldman HI;
    Am J Kidney Dis; 2022 Jan; 79(1):36-44.e1. PubMed ID: 34052355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
    Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
    Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
    Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Aragoncillo I; Verdalles U; Mosse A; Luño J
    Kidney Int Suppl; 2008 Dec; (111):S67-70. PubMed ID: 19034331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
    J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CKD and mortality risk in older people: a community-based population study in the United Kingdom.
    Roderick PJ; Atkins RJ; Smeeth L; Mylne A; Nitsch DD; Hubbard RB; Bulpitt CJ; Fletcher AE
    Am J Kidney Dis; 2009 Jun; 53(6):950-60. PubMed ID: 19394727
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.